Litigation Update: Amgen v. Hospira

Amgen v. Hospira (epoetin alfa)

As we reported yesterday in the Amgen v. Hospira litigation, Amgen filed a motion for leave to file an amended brief in support of its Motion for a Preliminary Injunction, in light of the Supreme Court’s ruling in Sandoz v. Amgen.  That same day, the Court entered an order granting Amgen’s request and setting forth a briefing schedule, with briefing complete by mid-July.

We also previously reported that Hospira filed a motion for summary judgment of non-infringement.  Briefing on the motion completed on June 9, 2017, and the Court has scheduled oral argument for June 28, 2017, at 9:00 a.m.

Stay tuned for further developments regarding this case at Big Molecule Watch.

Download PDF

Comments are closed.